The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Inflammation in central nervous system injury
Open accessAbstract
Inflammation is a key component of host defence responses to peripheral inflammation and injury, but it is now also recognized as a major contributor to diverse, acute and chronic central nervous system (CNS) disorders. Expression of inflammatory mediators including complement, adhesion molecules, cyclooxygenase enzymes and their products and cytokines is increased in experimental and clinical neurodegenerative disease, and intervention studies in experimental animals suggest that several of these factors contribute directly to neuronal injury. Most notably, specific cytokines, such as interleukin–1 (IL–1), have been implicated heavily in acute neurodegeneration, such as stroke and head injury. In spite of their diverse presentation, common inflammatory mechanisms may contribute to many neurodegenerative disorders and in some (e.g. multiple sclerosis) inflammatory modulators are in clinical use. Inflammation may have beneficial as well as detrimental actions in the CNS, particularly in repair and recovery. Nevertheless, several anti–inflammatory targets have been identified as putative treatments for CNS disorders, initially in acute conditions, but which may also be appropriate to chronic neurodegenerative conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biology of Oligodendrocyte and Myelin in the Mammalian Central Nervous System
Baumann, N., & Pham-Dinh, D. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.871 · Cited by 1,828
Microglia as a source and target of cytokines
Hanisch, U. (2002) · Glia · doi:10.1002/glia.10161 · Cited by 1,645
Recommendations for Standards Regarding Preclinical Neuroprotective and Restorative Drug Development
(1999) · Stroke · doi:10.1161/01.str.30.12.2752 · Cited by 1,251
Inflammation in Neurodegenerative Disease—A Double-Edged Sword
Wyss-Coray, T., & Mucke, L. (2002) · Neuron · doi:10.1016/s0896-6273(02)00794-8 · Cited by 1,235
Cytokines and acute neurodegeneration
Allan, S. M., & Rothwell, N. J. (2001) · Nature Reviews Neuroscience · doi:10.1038/35094583 · Cited by 1,123
Self-citationMicroglia as neuroprotective, immunocompetent cells of the CNS
Streit, W. J. (2002) · Glia · doi:10.1002/glia.10154 · Cited by 919
Clinical trials in head injury
Narayan, R. K., Michel, M. E., Ansell, B., Baethmann, A., Biegon, A., Bracken, M. B., Bullock, M. R., Choi, S. C., Clifton, G. L., Contant, C. F., et al. (2002) · Journal of Neurotrauma · doi:10.1089/089771502753754037 · Cited by 913
Chen, Y., & Swanson, R. A. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200302000-00001 · Cited by 912
Acute axonal injury in multiple sclerosis: Correlation with demyelination and inflammation
Bitsch, A. (2000) · Brain · doi:10.1093/brain/123.6.1174 · Cited by 898
Raivich, G., Bohatschek, M., Kloss, C. U. A., Werner, A., Jones, L. L., & Kreutzberg, G. W. (1999) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00007-7 · Cited by 844
Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide.
Merrill, J. E., Ignarro, L. J., Sherman, M. P., Melinek, J., & Lane, T. E. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.4.2132 · Cited by 781
The balance between IL-1 and IL-1Ra in disease
Arend, W. P. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(02)00020-5 · Cited by 721
Innate immunity: the missing link in neuroprotection and neurodegeneration?
Nguyen, M. D., Julien, J.-P., & Rivest, S. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn752 · Cited by 701
Interleukin 1 in the brain: biology, pathology and therapeutic target
Rothwell, N. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01661-1 · Cited by 671
Self-citationdel Zoppo, G., Ginis, I., Hallenbeck, J. M., Iadecola, C., Wang, X., & Feuerstein, G. Z. (2000) · Brain Pathology · doi:10.1111/j.1750-3639.2000.tb00247.x · Cited by 662
Iadecola, C., Zhang, F., Casey, R., Nagayama, M., & Ross, M. E. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-23-09157.1997 · Cited by 661
Vezzani, A., Conti, M., De Luigi, A., Ravizza, T., Moneta, D., Marchesi, F., & De Simoni, M. G. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-12-05054.1999 · Cited by 584
Li, Y., Liu, L., Barger, S. W., & Griffin, W. S. T. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-05-01605.2003 · Cited by 563
Use of anti-ICAM-1 therapy in ischemic stroke: Results of the Enlimomab Acute Stroke Trial
Enlimomab Acute Stroke Trial Investigators (2001) · Neurology · doi:10.1212/wnl.57.8.1428 · Cited by 544
Combating Hyperthermia in Acute Stroke: A Significant Clinical Concern
Ginsberg, M. D., & Busto, R. (1998) · Stroke · doi:10.1161/01.str.29.2.529 · Cited by 485
Role of IL-1α and IL-1β in Ischemic Brain Damage
Boutin, H., LeFeuvre, R. A., Horai, R., Asano, M., Iwakura, Y., & Rothwell, N. J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-15-05528.2001 · Cited by 477
Self-citationInflammatory processes in amyotrophic lateral sclerosis
McGeer, P. L., & McGeer, E. G. (2002) · Muscle & Nerve · doi:10.1002/mus.10191 · Cited by 470
The impact of systemic infection on the progression of neurodegenerative disease
Perry, V. H., Newman, T. A., & Cunningham, C. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1032 · Cited by 428
Iadecola, C., Niwa, K., Nogawa, S., Zhao, X., Nagayama, M., Araki, E., Morham, S., & Ross, M. E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.3.1294 · Cited by 411
Cytokines as Endogenous Pyrogens
Dinarello, C. A. (1999) · The Journal of Infectious Diseases · doi:10.1086/513856 · Cited by 387
Quagliarello, V. J., Wispelwey, B., Long, W. J., & Scheld, W. M. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115140 · Cited by 372
Olsson, T., Zhi, W. W., Höjeberg, B., Kostulas, V, Jiang, Y. P., Anderson, G., Ekre, H. P., & Link, H. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114800 · Cited by 368
Junctional complexes of the blood–brain barrier: permeability changes in neuroinflammation
Petty, M. A., & Lo, E. H. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00128-4 · Cited by 360
Cytokines and the central nervous system
Szelényi, J. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00428-2 · Cited by 358
Complement components of the innate immune system in health and disease in the CNS
Gasque, P., Dean, Y. D., McGreal, E. P., VanBeek, J., & Morgan, B. P. (2000) · Immunopharmacology · doi:10.1016/s0162-3109(00)80302-1 · Cited by 343
Rieckmann, P., Albrecht, M., Kitze, B., Weber, T., Tumani, H., Broocks, A., Lüer, W., Helwig, A., & Poser, S. (1995) · Annals of Neurology · doi:10.1002/ana.410370115 · Cited by 334
Wong, D., & Dorovini-Zis, K. (1992) · Journal of Neuroimmunology · doi:10.1016/0165-5728(92)90170-p · Cited by 301
Brain temperature, body core temperature, and intracranial pressure in acute cerebral damage
Rossi, S. (2001) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.71.4.448 · Cited by 301
Interleukin-18 Involvement in Hypoxic–Ischemic Brain Injury
Hedtjärn, M., Leverin, A.-L., Eriksson, K., Blomgren, K., Mallard, C., & Hagberg, H. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-14-05910.2002 · Cited by 290
Vartanian, T. K., Li, Y., Zhao, M., & Stefánsson, K. (1995) · PubMed Central · Cited by 285
Inflammation and Infection in Clinical Stroke
Emsley, H. C. A., & Tyrrell, P. J. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200212000-00001 · Cited by 276
Kanemoto, K., Kawasaki, J., Miyamoto, T., Obayashi, H., & Nishimura, M. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200005)47:5<571::aid-ana3>3.0.co;2-a · Cited by 263
Vartanian, T., Li, Y., Zhao, M., & Stefansson, K. (1995) · Molecular Medicine · doi:10.1007/bf03401888 · Cited by 261
Similarities between Alzheimer's disease and vascular dementia
Kalaria, R. (2002) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00256-3 · Cited by 259
Traumatic Brain Injury as a Risk Factor for Alzheimer's Disease: A Review
Lye, T. C., & Shores, E. A. (2000) · Neuropsychology Review · doi:10.1023/a:1009068804787 · Cited by 258
Pathogenesis of Cerebral Malaria: Recent Experimental Data and Possible Applications for Humans
Lou, J., Lucas, R., & Grau, G. E. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.810-820.2001 · Cited by 256
Local Neuroinflammation and the Progression of Alzheimer's Disease
McGeer, P. L., & McGeer, E. G. (2002) · Journal of Neurovirology · doi:10.1080/13550280290100969 · Cited by 255
Gary, D. S., Bruce-Keller, A. J., Kindy, M. S., & Mattson, M. P. (1998) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199812000-00001 · Cited by 249
Griffin, W. S. T., & Mrak, R. E. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.72.2.233 · Cited by 248
Oligodendrocytes as providers of growth factors
Du, Y., & Dreyfus, C. F. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10245 · Cited by 247
Hara, H., Fink, K., Endres, M., Friedlander, R. M., Gagliardini, V., Yuan, J., & Moskowitz, M. A. (1997) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199704000-00002 · Cited by 233
Holmin, S., & Mathiesen, T. (2000) · Journal of Neurosurgery · doi:10.3171/jns.2000.92.1.0108 · Cited by 230
Inflammation in the nervous system
Perry, V. H., Bell, M. D., Brown, H. C., & Matyszak, M. K. (1995) · Current Opinion in Neurobiology · doi:10.1016/0959-4388(95)80069-7 · Cited by 228
Brian de Souza, J., & Riley, E. M. (2002) · Microbes and Infection · doi:10.1016/s1286-4579(02)01541-1 · Cited by 223
Microglia in neurodegeneration: Molecular aspects
Gebicke‐Haerter, P. J. (2001) · Microscopy Research and Technique · doi:10.1002/jemt.1120 · Cited by 212
Blamire, A. M., Anthony, D. C., Rajagopalan, B., Sibson, N. R., Perry, V. H., & Styles, P. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-21-08153.2000 · Cited by 210
Microglia in human immunodeficiency virus‐associated neurodegeneration
Garden, G. A. (2002) · Glia · doi:10.1002/glia.10155 · Cited by 206
Interleukin‐10 modulates neuronal threshold of vulnerability to ischaemic damage
Grilli, M., Barbieri, I., Basudev, H., Brusa, R., Casati, C., Lozza, G., & Ongini, E. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00090.x · Cited by 197
Polymorphisms in Inflammatory Genes and the Risk of Alzheimer Disease
McGeer, P. L. (2001) · Archives of Neurology · doi:10.1001/archneur.58.11.1790 · Cited by 192
Furlan, R., Brambilla, E., Ruffini, F., Poliani, P. L., Bergami, A., Marconi, P. C., Franciotta, D. M., Penna, G., Comi, G., Adorini, L., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1821 · Cited by 188
Lack of Interleukin-6 Expression Is Not Protective Against Focal Central Nervous System Ischemia
Clark, W. M., Rinker, L. G., Lessov, N. S., Hazel, K., Hill, J. K., Stenzel-Poore, M., & Eckenstein, F. (2000) · Stroke · doi:10.1161/01.str.31.7.1715 · Cited by 187
Soriano, S. G., Lipton, S. A., Wang, Y. F., Xaio, M., Springer, T. A., Gutierrez‐Ramos, J., & Hickey, P. R. (1996) · Annals of Neurology · doi:10.1002/ana.410390511 · Cited by 186
Cortical Spreading Depression Induces Proinflammatory Cytokine Gene Expression in the Rat Brain
Jander, S., Schroeter, M., Peters, O., Witte, O. W., & Stoll, G. (2001) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200103000-00005 · Cited by 178
Transgenic mouse models of Alzheimer's disease
Janus, C., & Westaway, D. (2001) · Physiology & Behavior · doi:10.1016/s0031-9384(01)00524-8 · Cited by 176
Blood-borne interleukin-1 receptor antagonist crosses the blood-brain barrier
GUTIERREZ, E., BANKS, W., & KASTIN, A. (1994) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)90005-1 · Cited by 175
Benveniste, E. N., & Benos, D. J. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.15.8529837 · Cited by 173
Liu, X.-H., Kwon, D., Schielke, G. P., Yang, G.-Y., Silverstein, F. S., & Barks, J. D. E. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199910000-00006 · Cited by 168
Touzani, O., Boutin, H., Feuvre, R. A. L., Parker, L. C., Miller, A. J., Luheshi, G. N., & Rothwell, N. J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-01-00038.2002 · Cited by 141
Self-citationCzłonkowska, A., Kurkowska‐Jastrzębska, I., Członkowski, A., Peter, D., & Stefano, G. B. (2002) · PubMed · Cited by 133
Inflammation in the CNS: balance between immunological privilege and immune responses
Matyszak, M. K. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00014-8 · Cited by 132
Elder, M. (1997) · KARGER eBooks · doi:10.1159/000060714 · Cited by 126
Drug development for stroke: importance of protecting cerebral white matter
Dewar, D., Yam, P. S., & McCulloch, J. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00280-0 · Cited by 125
Migration of Multiple Sclerosis Lymphocytes Through Brain Endothelium
Prat, A., Biernacki, K., Lavoie, J.-F., Poirier, J., Duquette, P., & Antel, J. P. (2002) · Archives of Neurology · doi:10.1001/archneur.59.3.391 · Cited by 121
Association of interleukin-1β polymorphisms with idiopathic Parkinson's disease
McGeer, P. L., Yasojima, K., & McGeer, E. G. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00300-2 · Cited by 118
Goldberg, M. P., & Ransom, B. R. (2003) · Stroke · doi:10.1161/01.str.0000054048.22626.b9 · Cited by 118
Polymorphisms in the interleukin-1 alpha and beta genes and the risk for Parkinson's disease
Schulte, T., Schöls, L. J., Müller, T. H., Woitalla, D., Berger, K., & Krüger, R. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00301-4 · Cited by 117
Connecting cytokines and brain: a review of current issues.
Quan, N., & Herkenham, M. A. (2002) · PubMed · doi:10.14670/hh-17.273 · Cited by 113
Do NSAIDs prevent Alzheimer's disease? And, if so, why? The epidemiological evidence
Zandi, P. P., & Breitner, J. C. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00297-4 · Cited by 108
Neurological Sequelae of Boxing
Guterman, A., & SMITH, R. W. (1987) · Sports Medicine · doi:10.2165/00007256-198704030-00004 · Cited by 98
Coclet-Ninin, J., Dayer, J. M., & Burger, D. (1997) · PubMed · Cited by 90
Pasinetti, G. M. (2002) · Journal of Alzheimer s Disease · doi:10.3233/jad-2002-4510 · Cited by 89
Diagnosis and management of vascular cognitive impairment and dementia
Erkinjuntti, T. (2002) · Springer eBooks · doi:10.1007/978-3-7091-6137-1_6 · Cited by 88
The role of cytokines, astrocytes, microglia and apoptosis in Creutzfeldt-Jakob disease
Everbroeck, B. V., Dewulf, E. M., Pals, P., Lübke, U., Martin, J., & Cras, P. P. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00236-6 · Cited by 88
Bresnihan, B. (2001) · Seminars in Arthritis and Rheumatism · doi:10.1053/sarh.2001.23701 · Cited by 85
IFNs Are Critical Regulators of IL-1 Receptor Antagonist and IL-1 Expression in Human Microglia
Liu, J. S.-H., Amaral, T. D., Brosnan, C. F., & Lee, S. C. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.4.1989 · Cited by 83
Jellinger, K. A., Paulus, W., Wrocklage, C., & Litvan, I. (2001) · European Journal of Neurology · doi:10.1046/j.1468-1331.2001.00322.x · Cited by 80
Bonmann, E., Suschek, C. V., Spranger, M., & Kolb-Bachofen, V. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00485-0 · Cited by 76
Emerging Therapies for Acute Ischemic Stroke
Fisher, M., & Brott, T. G. (2003) · Stroke · doi:10.1161/01.str.0000054627.69159.c2 · Cited by 75
Rat models as tool to develop new immunotherapies
Link, H., & Xiao, B. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1840111.x · Cited by 64
Pharmacological interventions for stroke: failures and future
Tuma, R. F., Legos, J. J., & Barone, F. C. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.5.603 · Cited by 63
Pharmacogenomics of neurodegenerative diseases
Maimone, D., Dominici, R., & Grimaldi, L. M. E. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00939-0 · Cited by 56
Ohtaki, H., Funahashi, H., Dohi, K., Oguro, T., Horai, R., Asano, M., Iwakura, Y., Li, Y., Matsunaga, M., Noboru, G. O. T. O., et al. (2003) · Neuroscience Research · doi:10.1016/s0168-0102(02)00238-9 · Cited by 50
Utilization of Genetically Altered Animals in the Pharmaceutical Industry
Rudmann, D. G., & Durham, S. K. (1999) · Toxicologic Pathology · doi:10.1177/019262339902700121 · Cited by 45
Interactions between lymphocytes, macrophages, and central nervous system cells
Couraud, P. (1994) · Journal of Leukocyte Biology · doi:10.1002/jlb.56.3.407 · Cited by 40
The contribution of inflammation to acute and chronic neurodegeneration
Perry, V. H., Bolton, S. J., Anthony, D. C., & Betmouni, S. (1998) · Research in Immunology · doi:10.1016/s0923-2494(99)80046-7 · Cited by 36
Silknitter, J. (1935) · Cited by 32
The Role of Cytokines in Experimental Autoimmune Encephalomyelitis
Bettelli, E., & Nicholson, L. B. (2001) · Springer eBooks · doi:10.1007/978-94-010-0981-2_9 · Cited by 20
Cited by
Microglia in neurodegenerative disease
Perry, V. H., Nicoll, J. A. R., & Holmes, C. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.17 · Cited by 1,543
Lamptey, R. N. L., Chaulagain, B., Trivedi, R., Gothwal, A., Layek, B., & Singh, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031851 · Cited by 900
Repairing the human brain after stroke: I. Mechanisms of spontaneous recovery
Cramer, S. C. (2008) · Annals of Neurology · doi:10.1002/ana.21393 · Cited by 875
Leonard, B., & Maes, M. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.12.005 · Cited by 805
Secondary injury mechanisms in traumatic spinal cord injury: a nugget of this multiply cascade
Oyinbo, C. (2011) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2011-1848 · Cited by 786
Metadata
- Authors
- Allan, S. M., & Rothwell, N. J.
- Venue
- Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences
- Publisher
- The Royal Society
- Published
- 2003-08-27
- Volume
- 358
- Issue
- 1438
- Pages
- 1669-1677
- ISSN
- 0962-8436 (ISSN-L)
- 1471-2970
- OpenAlex
- W2007511428
- Cited by
- 345
- References
- 92
- FWCI
- 9.31
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.